BioPharm International eBulletin
Having trouble viewing this e-mail? CLICK HERE

BioPharm International
March 17, 2020
WEBSITE CURRENT ISSUE SUBSCRIBE FORWARD
advertisement

TOP STORIES


INTERPHEX Rescheduled Due to COVID-19

The event, which was originally scheduled to take place April 28–30 at the Javits Center in New York City, has been rescheduled for July 15–17 at the same location.
/ read more /

ADVERTISEMENT

Featured Resources from BioPharm International
View our online resource center, sponsored by GE Healthcare, to explore a case study and articles on gaining and retaining skilled labor, modular bioprocessing, the good and bad of biosilimiars, and more.
Learn More »

 

CPhI North America Rescheduled Amid
Coronavirus Outbreak

The CPhI event, which was originally scheduled for May 5–7, 2020 at the Pennsylvania Convention Center in Philadelphia, PA, will be rescheduled for Sept. 9–11, 2020 at the same venue.
/ read more /

advertisement
 

Subscribe

Subscribers can enjoy each full issue of BioPharm International in print, or via BioPharm apps.

subscription offers
subscribe

ADVERTISEMENT

Introducing Pre-packed EconoFit Chromatography Columns
EconoFit Columns are disposable, low-pressure chromatography columns. These prepacked columns are available for a variety of chromatographic techniques, including affinity (AC), ion exchange (IEX) and desalting (size exclusion [SEC]). They are easy-to-use and ready to connect to chromatography systems using common 10-32fittings.
Learn More »

 

Industry News


The Bill & Melinda Gates Foundation, Wellcome, and Mastercard Pledge $125 Million to Accelerated COVID-19 Response

The project, which will be titled the COVID-19 Therapeutics Accelerator, will work to pinpoint which new and repurposed drugs and biologics can treat patients immediately, and which can treat patients long-term.
/ read more /


FDA Grants Breakthrough Therapy Designation to J&J’s Lung Cancer Therapy

The decision comes after results were received from a Phase 1, open-label study that evaluated the safety, pharmacokinetics, and preliminary efficacy of the monotherapy.
/ read more /


MORE INDUSTRY NEWS
 


advertisement

Biopharma News


Emergent and Novavx Sign Agreement for Experimental COVID-19 Vaccine

Through the agreement, Emergent will manufacture the vaccine, which is formulated based on Novavax’s proprietary recombinant protein nanoparticle technology platform and its Matrix-M adjuvant to boost immune responses.
/ read more /


CEL-SCI Begins Development of Immunotherapy for COVID-19

The company is using its LEAPS peptide technology to develop the immunotherapy, which may be able to reduce COVID-19 viral load and tissue damage.
/ read more /


More Biopharma News
 

Supplier News


Bora to Acquire GSK’s Canadian Facility

Through the agreement, Bora will obtain ownership of the entire Mississauga site, including all facilities, under the proper regulatory clearances.
/ read more /



Zuellig, Hellman, and Modum Join Poseidon’s Pharma Ocean Freight Network

Launched in 2018, the Poseidon network works to bring together pharmaceutical providers to reform the pharmaceutical logistics process.
/ read more /


More Supplier News

Regulatory News


FDA Postpones Foreign Inspections

The agency is postponing the inspection of most foreign facilities through April 2020.
/ read more /



FDA and CDC Increase Access to Respirators Amid COVID-19 Outbreak

The action involves allowing specific National Institute for Occupational Safety and Health-approved respirators not regulated by FDA to be used in healthcare settings to increase the number of respirators available in the United States.
/ read more /


More Regulatory News

FEATURED TOPICS

QUALITY SYSTEMS

Coronavirus Response: Reaction or New Reality?

Emergency actions to protect patients and the drug supply may have long-term implications.
/ read more /

 

BIOBUSINESS

The Costs of Commercializing CRISPR

As patent disputes within the scientific community continue, drug developers consider the intellectual property unknowns associated with this emerging technology.
/ read more /


ANALYTICS

Stability Testing: The Crucial Development Step

As compounds become more complex in nature and biological ingredients are more widely used, stability testing approaches must follow suit and provide flexibility for developers.
/ read more /

UPSTREAM PROCESSING

Improving Upstream Predictability

Better understanding and control of cell behavior is yielding benefits, upstream and beyond.
/ read more /


PRODUCT/SERVICES PROFILES

The Power to Make

Ajinomoto Bio-Pharma Services is a fully integrated contract development and manufacturing organization, providing comprehensive process development services, cGMP manufacturing and drug product fill/finish services of small-molecule and biologic APIs and intermediates.
/ read more /

Next-Generation Biopharmaceutical Development Services

Catalent Biologics is a global leader in biopharmaceutical development services, bringing next-generation therapies to the market.
/ read more /

WEBCASTS


Understanding Oligonucleotides from Every Angle: Utilizing Mass Spectrometry for Characterization and Quantification
Tuesday, March 17, 2020 at 11am EDT | 8am PDT | 3pm GMT | 4pm CET
Learn More



TAKE THE SURVEY

17th Annual BioPlan Associates' Biopharmaceutical Manufacturing Report

Expert input is needed for the bio-industry's most in-depth, global benchmarking and analysis study, which examines current global and regional trends affecting the bioindustry. Participants who complete the survey receive a free aggregated summary of the study results, a free whitepaper on the Top 15 Trends in Biopharmaceutical Manufacturing, and the opportunity to share insight about trends in biomanufacturing. For each completed survey, BioPlan Associates will contribute $10 (up to $3000) to a global health charity.
/ Take the survey /

 

Rescheduled or Postponed Events

CPhI South East Asia

CPhI South East Asia has been rescheduled for July 2020.

Interphex 2020

Interphex 2020 has been rescheduled for July 2020.

69th PDA Annual Meeting

PDA’s Annual Meeting has been rescheduled for July 2020.

Bioprocessing Summit Europe

Bioprocessing Summit Europe has been rescheduled for July 2020.

PDA Pharmaceutical Manufacturing Data Science Workshop

PDA’s Pharmaceutical Manufacturing Data Science Workshop has been rescheduled for July 2020.

CPhI North America

CPhI North America has been rescheduled for September 2020.

Analytica 2020

Analytica 2020 has been rescheduled for October 2020.

CPhI Japan

CPhI Japan has been postponed until further notice.

more events

eBook

Regulatory Sourcebook and Reference, December 2019

In BioPharm International’s Pharmacopoeia Compliance Series, experts explain the revision process for global and national pharmacopoeias, best practices for monitoring changes, and how to participate in revisions. Other features include FDA warning letters, FDA Form 483s, and essentials for quality risk management.

contribute | CONTACT EDITORS | CONTACT SALES | subscribe | advertise